Risk of rash in pd-1 or pd-l1-related cancer clinical trials: a systematic review and meta-analysis

HIGHLIGHTS

  • who: Yuan Tian and collaborators from the Radiotherapy Department, Shandong Second Provincial General Hospital, Jinan, Shandong, China Department of Cardiology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan have published the research work: Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis, in the Journal: Journal of Oncology 9 of 18/07/2022
  • what: Given that immune-related rash was the most frequently reported PD-1 or PD-L1-related skin toxicity this systematic review and meta-analysis were conducted to elucidate its . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?